IP Library Granted Patent US 6,989,257
Granted Patent B2
US 6,989,257 · App. 10/166,225 · Granted Jan 24, 2006

Isoprenoid production

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,989,257
App. No.
10/166,225
Granted
Jan 24, 2006
Kind
B2
Abstract

Isolated polynucleotides encoding polypeptides having the activity of enzymes in the mevalonate pathway are provided. These sequences are useful for recombinantly producing isoprenoid compounds, such as carotenoids, in particular zeaxanthin. Expression vectors, cultured cells, and methods of making isoprenoid compounds are also provided.

Claims (13)

1. An isolated polypeptide comprising an amino acid sequence selected from the group consisting of:

(a) SEQ ID NO: 43;

(b) an amino acid sequence of a fragment of a SEQ ID NO: 43 having hydroxymethylglutaryl-CoA reductase (HMG-CoA reductase) activity;

(c) an amino acid sequence of a polypeptide having HMG-CoA reductase activity, which is encoded by a polynucleotide that hybridizes to SEQ ID NO: 42 or a complement of SEQ ID NO: 42 under the following conditions: hybridization in 40% formamide, 1M NaCl, 1% sodium dodecyl sulfate (SDS) at 37° C., followed by at least one wash in 0.2×SSC at 60° C. for 20 minutes; and

(d) an amino acid sequence of a polypeptide having HMG-CoA reductase activity, which is at least 95% identical to SEQ ID NO: 43.

2. An isolated polypeptide of claim 1 having the amino acid sequence of SEQ ID NO: 43.

3. An isolated polypeptide of claim 2 consisting of the amino acid sequence of SEQ ID NO: 43.

4. An isolated polypeptide of claim 1 comprising an amino acid sequence of a polypeptide having HMG-CoA reductase activity, which is encoded by a polynucleotide that hybridizes to SEQ ID NO: 42 or a complement of SEQ ID NO: 42 under the following conditions: hybridization in 40% formamide, 1M NaCl. 1% SDS at 37° C., followed by at least one wash in 0.2×SSC at 60° C. for 20 minutes.

5. An isolated polypeptide of claim 4 consisting of an amino acid sequence of a polypeptide having HMG-CoA reductase activity, which is encoded by a polynucleotide that hybridizes to SEQ ID NO: 42 or a complement of SEQ ID NO: 42 under the following conditions: hybridization in 40% formamide, 1M NaCl, 1% SDS at 37° C., followed by at least one wash in 0.2×SSC at 60° C. for 20 minutes.

6. An isolated polypeptide of claim 1 comprising an amino acid sequence of a polypeptide having HMG-CoA reductase activity, which is at least 95% identical to SEQ ID NO: 43.

7. An isolated polypeptide of claim 6 consisting of an amino acid sequence of a polypeptide having HMG-CoA reductase activity, which is at least 95% identical to SEQ ID NO: 43.

8. An isolated polypeptide comprising an amino acid sequence of a fragment or SEQ ID NO: 43, which polypeptide has HMG-CoA reductase activity.

9. An isolated polypeptide of claim 4 consisting of an amino acid sequence of a fragment of SEQ ID NO: 43, which polypeptide has HMG-CoA reductase activity.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2004
From: ROCHE VITAMINS INC.
To: DSM IP ASSETS B.V.
Reel/Frame 015418/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2004
From: ROCHE VITAMINS INC.
To: DSM NUTRITIONAL PRODUCTS, INC.
Reel/Frame 015452/0973 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2002
From: BERRY, ALAN; BRETZEL, WERNER; HUMBELIN, MARKUS; MAYER, ANNE FRANCOISE; LOPEZ-ULIBARRI, RUAL; YELISEEV, ALEXEI
To: ROCHE VITAMINS INC.
Reel/Frame 013234/0499 →